1183P Sequential PRRT and SIRT: Evaluation of safety, toxicity and best sequence treatment in liver dominant GEPNETs

To investigate safety, tolerability and best sequence treatment in patients subjected to Peptide Radio-Receptor Therapy (PRRT) and Selective Internal Radiation Therapy (SIRT) for metastatic liver-dominant GEPNETs. Ninety-eight patients treated with PRRT and SIRT in our Institute, from 2012 to y2016, were retrospectively reviewed. Treatment toxicity was assessed according to CTCAE v5.0. Dosimetric analysis of dose administered by SIRT was...